|
|
|
|
LEADER |
00000pam a22000004a 4500 |
001 |
4334245 |
003 |
ICU |
005 |
20031020105300.0 |
008 |
991124s2000 enka b 001 0 eng c |
010 |
|
|
|a 99059424
|
020 |
|
|
|a 0192629727 (hbk : alk. paper)
|
035 |
|
|
|a 99059424
|
035 |
|
|
|a (DNLM)100901293
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC933
|b .R4286 2000
|
060 |
1 |
0 |
|a WE 346
|b R47302 2000
|
082 |
0 |
0 |
|a 616.7/227
|2 21
|
245 |
0 |
0 |
|a Rheumatoid arthritis :
|b frontiers in pathogenesis and treatment /
|c edited by Gary S. Firestein, Gabriel S. Panayi, and Frank A. Wollheim.
|
246 |
1 |
|
|i Subtitle from cover:
|a New frontiers in pathogenesis and treatment
|
260 |
|
|
|a Oxford ;
|a New York :
|b Oxford University Press,
|c 2000.
|
300 |
|
|
|a xv, 581 p. :
|b ill. (some col.) ;
|c 28 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g 1.
|t Current perspectives on the genetics of rheumatoid arthritis /
|r Mark Fife, Gerald Coakley and Jerry Lanchbury --
|g 2.
|t Epidemiology of rheumatoid arthritis /
|r Franz Calvo and Graciela S. Alarcon --
|g 3.
|t Infection in the pathogenesis of rheumatoid arthritis /
|r Gabrielle Kingsley --
|g 4.
|t Experimental models for rheumatoid arthritis /
|r Rikard Holmdahl --
|g 5.
|t Examination of the synovium and synovial fluid /
|r Paul-Peter Tak --
|g 6.
|t The role of macrophages in rheumatoid arthritis /
|r Raimund W. Kinne, Bruno Stuhlmuller and Ernesta Palombo-Kinne /
|r [et al.] --
|g 7.
|t The role of T lymphocytes in rheumatoid arthritis /
|r David A. Fox --
|g 8.
|t The role of neutrophils in rheumatoid arthritis /
|r W. Winn Chatham, Jeffrey C. Edberg and Robert P. Kimberly --
|g 9.
|t The role of fibroblast-like synoviocytein rheumatoid arthritis /
|r Percio S. Gulko, Tetsunori Seki and Robert Winchester --
|g 10.
|t Adhesion, migration, and cell trafficking /
|r Costantino Pitzalis --
|g 11.
|t Cytokine networks /
|r William R. Arend and Cem Gabay --
|g 12.
|t Apoptosis in rheumatoid arthritis: cause or consequence /
|r Nathan J. Zvaifler --
|g 13.
|t Rheumatoid factor /
|r Diego Kyburz and Dennis A. Carson --
|g 14.
|t Mechanisms of joint destruction /
|r Thomas Pap, Renate E. Gay and Steffen Gay --
|g 15.
|t Pain mechanisms in rheumatoid arthritis /
|r Bruce Kidd, Paul Mapp and David Blake --
|g 16.
|t Rheumatoid arthritis: clinical picture and its variants /
|r William F. Lems and Ben A. C. Dijkmans --
|g 17.
|t Extra-articular features of rheumatoid arthritis /
|r D. O'Gradaigh, R. A. Watts and D. G. I. Scott --
|g 18.
|t The neuroendocrine axis in rheumatoid arthritis /
|r Ronald L. Wilder and Ilia J. Elenkov --
|g 19.
|t Imaging /
|r Dolores Kalden-Nemeth and Bernhard Manger --
|g 20.
|t Outcome and mortality /
|r Marjatta Leirisalo-Repo --
|g 21.
|t Molecular markers for assessment of cartilage damage in rheumatoid arthritis /
|r Tore Saxne and Bengt Mansson --
|g 22.
|t NSAIDSs and analgesics /
|r Richard Day, David Quinn and Lynnette March /
|r [et al.] --
|g 23.
|t Systemic glucocorticoids in rheumatoid arthritis /
|r Roger Hallgren --
|g 24.
|t Methotrexate /
|r Rolf Rau --
|g 25.
|t Gold, antimalarials, sulfasalazine, and other DMARDs /
|r Piet L. C. M. van Riel and Eric-Jan J. A. Kroot --
|g 26.
|t Intra-articular therapy /
|r Peter Lanyon and Michael Doherty --
|g 27.
|t Combination therapy for rheumatoid arthritis /
|r Philip G. Conaghan and Peter M. Brooks --
|g 28.
|t The impact of physiotherapy /
|r Ulrich Moritz --
|g 29.
|t Occupational therapy and assistive technology /
|r Ulla Nordenskiold --
|g 30.
|t Diets /
|r Lars Skoldstam --
|g 31.
|t Psychological and social aspects /
|r Tore Kristian Kvien and Liv Marit Smedstad --
|g 32.
|t Patient education /
|r Ylva Lindroth --
|g 33.
|t Non-drug management of chronic pain /
|r Wolfgang Hamann --
|g 34.
|t Health economics /
|r Leigh F. Callahan --
|g 35.
|t Large joints and feet /
|r Urban Rydholm --
|g 36.
|t The hand /
|r Christer Sollerman --
|g 37.
|t The cervical spine /
|r A. T. H. Casey and H. A. Crockard --
|g 38.
|t Medical synovectomy (synoviorthesis) /
|r C. J. Menkes and S. Diallo --
|g 39.
|t Anticytokine therapy: TNF inhibitors and other novel approaches /
|r Tom W. J. Huizinga and Ferdinand C. Breedveld --
|g 40.
|t The design of clinical trials /
|r David L. Scott --
|g 41.
|t Anti-T lymphocyte therapies /
|r Ernest H. S. Choy --
|g 42.
|t Antimacrophage therapies /
|r Alison M. Badger --
|g 43.
|t Inhibition of matrix metalloproteinases in rheumatoid arthritis /
|r Tim Shaw --
|g 44.
|t Small molecule inhibitors of signal transduction /
|r Anthony M. Manning.
|
583 |
1 |
|
|a committed to retain
|c 20170930
|d 20421213
|f HathiTrust
|5 ICU
|
650 |
|
0 |
|a Rheumatoid arthritis.
|0 http://id.loc.gov/authorities/subjects/sh85113649
|
650 |
1 |
2 |
|a Arthritis, Rheumatoid
|x therapy.
|
650 |
2 |
2 |
|a Arthritis, Rheumatoid
|x physiopathology.
|
650 |
|
7 |
|a Rheumatoid arthritis.
|2 fast
|0 http://id.worldcat.org/fast/fst01097027
|
700 |
1 |
|
|a Firestein, Gary S.
|0 http://id.loc.gov/authorities/names/n80133571
|1 http://viaf.org/viaf/71563176
|
700 |
1 |
|
|a Panayi, Gabriel S.
|q (Gabriel Stavros)
|0 http://id.loc.gov/authorities/names/n78054141
|1 http://viaf.org/viaf/93651031
|
700 |
1 |
|
|a Wollheim, Frank A.
|0 http://id.loc.gov/authorities/names/n99804005
|1 http://viaf.org/viaf/2764173
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
035 |
|
|
|a (OCoLC)42890298
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i c65339ca-7001-5009-b63e-9074a1d472bf
|s 4bdfbb9c-9724-5e6e-a7ec-a6a7831e513e
|
928 |
|
|
|t Library of Congress classification
|a RC933 .R4286 2000
|l JCL
|c JCL-Sci
|i 4592954
|
927 |
|
|
|t Library of Congress classification
|a RC933 .R4286 2000
|l JCL
|c JCL-Sci
|e MAYB
|e CRERAR
|b 56476398
|i 6919766
|